● MGC Pharmaceuticals (MXC) has executed a multi-year binding agreement to supply
cannabidiol (CBD) extract from its European facility to European distributor Mabsut Life
(Mabsut Agriculture d.o.o)
● Under the agreement MXC will supply a specialised CBD extract to Mabsut Life at a
minimum of 12kg of CBD extract per quarter
● This contract effectively commences immediately, with an initial Purchase Order of 2kg of
extract has already been placed by Mabsut Life under the binding agreement, which
includes the initial pre-payment of US$40,000 due within 2 weeks
● This single binding contract is expected to generate in excess of $1m in annual sales
● The CBD supplied will be commercialised by Mabsut into cartridges for vape pens under
their Mabsut brand and distributed throughout their sales network in Europe
● Mabsut Life is a lifestyle & medical cannabis product manufacturer and distributor focused
on the various segments of the emerging European supply chain, operating in Germany, the
Czech Republic and Austria
● The specialised extract has been developed and produced to an agreed formula using MGC
Pharma’s leading Research and Development facilities in Slovenia
MXC Price at posting:
9.4¢ Sentiment: Hold Disclosure: Held
